What the evidence says. Anticancer activity exists only in cell and mouse studies, which are themselves inconsistent; there are no human clinical trials, the one published human 'remission' series was retracted, and case reports document real liver harm. (No Evidence evidence: No credible human evidence supports the marketed claims — widely considered ineffective.)
⚠
Health warning. Fenbendazole is not approved for people; self-dosing for cancer has caused severe drug-induced liver injury, can be mistaken for immunotherapy side effects, and must never replace or delay proven cancer treatment.
What is Fenbendazole (Off-label Cancer Use)?
Fenbendazole (Off-label Cancer Use) (Benzimidazole veterinary anthelmintic) is a debunked supplement marketed for cures or shrinks cancer ('joe tippens protocol'). NutriDex grades the human evidence as No Evidence. Fenbendazole is a cheap, effective veterinary dewormer for dogs, cats and livestock; it has never been approved for human use. Its fame as a cancer cure traces to a 2019 viral anecdote (the 'Joe Tippens protocol') whose originator has said he was also enrolled in a conventional cancer-drug trial at the time. In lab dishes fenbendazole disrupts microtubules and glucose uptake in cancer cells, and some mouse xenograft studies show slower tumour growth, but others, including a Yale diet study and a mouse lymphoma model, found no effect in living animals. No completed human clinical trial has tested fenbendazole for any cancer. The only published human 'remission' series (three patients, 2025) was retracted in 2026 over an undisclosed financial conflict of interest, and such anecdotes cannot separate fenbendazole from co-treatments. Meanwhile, a growing set of case reports documents serious drug-induced liver injury in people self-dosing, sometimes while on immunotherapy, where it mimicked immune hepatitis.
Marketed Claims (unproven)
✕(Claimed) cures or shrinks cancer ('Joe Tippens protocol')
✕(Claimed) starves tumours by blocking glucose uptake
✕(Claimed) safe, cheap alternative to chemotherapy
✕(Proven, veterinary only) treats intestinal worms in dogs, cats and livestock
Dosing & Compounds
Use & Legality
Not approved for any human use and no human dose has been established. Veterinary products are dosed by the animal's body weight, for parasites only. Do not self-treat; discuss any interest in drug repurposing with your oncologist.
Case reports from the US and Japan describe severe hepatocellular liver injury, including jaundice, in people self-dosing fenbendazole for cancer; injury usually resolves after stopping but can be misread as immunotherapy hepatitis, leading to unnecessary steroids or paused cancer treatment. Veterinary products are not made or dosed for humans, and related benzimidazoles can suppress the bone marrow and are avoided in pregnancy. Anyone with cancer, liver disease or on immunotherapy or chemotherapy should not take it, and should tell their oncologist about any self-medication. The biggest risk is delaying or abandoning effective treatment. Educational only — always check with your doctor or pharmacist before combining Fenbendazole (Off-label Cancer Use) with any medicine.
Common questions about Fenbendazole (Off-label Cancer Use)
What is Fenbendazole (Off-label Cancer Use) used for?
Fenbendazole (Off-label Cancer Use) is most often marketed for (Claimed) cures or shrinks cancer ('Joe Tippens protocol'), (Claimed) starves tumours by blocking glucose uptake, (Claimed) safe, cheap alternative to chemotherapy, (Proven, veterinary only) treats intestinal worms in dogs, cats and livestock. A good dog dewormer; an unproven, liver-toxic cancer self-treatment.
Does Fenbendazole (Off-label Cancer Use) work — what does the evidence say?
No Evidence evidence. No credible human evidence supports the marketed claims — widely considered ineffective. Fenbendazole is a cheap, effective veterinary dewormer for dogs, cats and livestock; it has never been approved for human use. Its fame as a cancer cure traces to a 2019 viral anecdote (the 'Joe Tippens protocol') whose originator has said he was also enrolled in a conventional cancer-drug trial at the time. In lab dishes fenbendazole disrupts microtubules and glucose uptake in cancer cells, and some mouse xenograft studies show slower tumour growth, but others, including a Yale diet study and a mouse lymphoma model, found no effect in living animals. No completed human clinical trial has tested fenbendazole for any cancer. The only published human 'remission' series (three patients, 2025) was retracted in 2026 over an undisclosed financial conflict of interest, and such anecdotes cannot separate fenbendazole from co-treatments. Meanwhile, a growing set of case reports documents serious drug-induced liver injury in people self-dosing, sometimes while on immunotherapy, where it mimicked immune hepatitis.
What is the typical dose of Fenbendazole (Off-label Cancer Use)?
Not approved for any human use and no human dose has been established. Veterinary products are dosed by the animal's body weight, for parasites only. Do not self-treat; discuss any interest in drug repurposing with your oncologist.
Is Fenbendazole (Off-label Cancer Use) safe? Any cautions or side effects?
Case reports from the US and Japan describe severe hepatocellular liver injury, including jaundice, in people self-dosing fenbendazole for cancer; injury usually resolves after stopping but can be misread as immunotherapy hepatitis, leading to unnecessary steroids or paused cancer treatment. Veterinary products are not made or dosed for humans, and related benzimidazoles can suppress the bone marrow and are avoided in pregnancy. Anyone with cancer, liver disease or on immunotherapy or chemotherapy should not take it, and should tell their oncologist about any self-medication. The biggest risk is delaying or abandoning effective treatment.
How many studies support Fenbendazole (Off-label Cancer Use)?
NutriDex cites 10 sources for Fenbendazole (Off-label Cancer Use), graded "No Evidence".
Cite this page
APA
Peh, D. (2026). Fenbendazole (Off-label Cancer Use) (Benzimidazole veterinary anthelmintic): Benefits, Dosage, Side Effects & Evidence. NutriDex — The Supplement Research Compendium. Retrieved 18 Oct 2026, from https://nutridex.info/s/fenbendazole
BibTeX
@misc{nutridex_fenbendazole,
author = {Peh, Daryl},
title = {Fenbendazole (Off-label Cancer Use) (Benzimidazole veterinary anthelmintic): Benefits, Dosage, Side Effects \& Evidence},
year = {2026},
howpublished = {NutriDex --- The Supplement Research Compendium},
url = {https://nutridex.info/s/fenbendazole},
note = {Reviewed by Dr Daryl Peh, MBBS Singapore, MMed FM. Accessed 2026-10-18}
}
For medical claims, citing the underlying primary studies linked above is preferred. NutriDex is an educational reference, not medical advice.